Do specific types of sleep disturbances represent risk factors for poorer health‐related quality of life in inflammatory bowel disease? A longitudinal cohort study
| Autor: | Alexander J Scott, Olivia Flowers, Georgina Rowse |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
medicine.medical_specialty
Psychological intervention Inflammatory bowel disease law.invention Cohort Studies 03 medical and health sciences 0302 clinical medicine Quality of life Randomized controlled trial Risk Factors law Surveys and Questionnaires Insomnia Humans Medicine Longitudinal Studies 030212 general & internal medicine Applied Psychology Depression (differential diagnoses) 030505 public health Depression business.industry General Medicine Inflammatory Bowel Diseases medicine.disease Quality of Life Physical therapy Anxiety Observational study medicine.symptom Sleep 0305 other medical science business RA RC |
| Zdroj: | British Journal of Health Psychology. 26:90-108 |
| ISSN: | 2044-8287 1359-107X |
| DOI: | 10.1111/bjhp.12457 |
| Popis: | Objectives\ud \ud Poor global sleep quality is commonly reported in people with inflammatory bowel disease (IBD) and is linked to poorer health‐related quality of life (HRQoL). However, understanding is currently limited by a lack of: (1) longitudinal research and (2) research investigating the impact of specific types of problems sleeping on IBD‐related outcomes, particularly on HRQoL.\ud \ud \ud \ud Design\ud \ud Observational longitudinal cohort study.\ud \ud \ud \ud Methods\ud \ud N = 276 participants with IBD completed measures at baseline (T1) and 4 weeks later at T2. Four specific sleep disturbances associated with IBD including sleep apnoea, insomnia, restless legs, and nightmares were measured alongside depression, anxiety and stress, and HRQoL.\ud \ud \ud \ud Results\ud \ud After controlling for participant demographics and clinical characteristics, T1 depression, anxiety, stress, and T1 HRQoL, more severe symptom severity of sleep apnoea (B = −0.30, p < .05) and insomnia symptoms (B = −0.23, p < .05) at T1 significantly predicted poorer HRQoL at T2. However, the experience of restless legs (B = −0.03, p > .87) and nightmares (B = −0.14, p > .11) at T1 did not predict HRQoL.\ud \ud \ud \ud Conclusion\ud \ud Symptoms synonymous with sleep apnoea and insomnia might represent modifiable risk factors that provide independent contributions to HRQoL over time in those with IBD. These findings suggest that interventions designed to improve sleep apnoea and insomnia could confer benefits to HRQoL in those with IBD. However, more longitudinal research is needed to understand the contribution of sleep disturbances over the longer term, as well as more randomized controlled trials testing the effect of improving sleep on IBD‐related outcomes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|